Capricor sues Nippon Shinyaku over Duchenne drug 'pricing flaw' and launch prep

Capricor Therapeutics said Thursday it has filed a lawsuit against Nippon Shinyaku over a distribution and commercialization agreement for deramiocel, a cell therapy candidate for Duchenne muscular dystrophy (DMD) that’s getting a second chance at ...